Generics 10

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Dexlansoprazole manufacturers

10 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

10 products found

dexlansoprazole

Capsules 30 mg, 60 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #22627

This CTD dossier owner and manufacturer was founded in 2007 and has two manufacturing facilities strategically located in India. They boast over 1,800 products spanning a range of therapeutic areas, including those focused on dermatology, pain management, and possibly central nervous system disorders based on the listed divisions. The company produces both prescription medications and over-the-counter drugs, utilizing diverse dosage forms such as tablets and capsules. They maintain a strong national network for distribution and a global presence. GMP certifications are likely held due to their focus on quality manufacturing practices.

Manufacturer usually replies in 4 days

dexlansoprazole

Capsules, delayed release (DR) 30 mg, 60 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 6 days

dexlansoprazole

Capsules 30 mg, 60 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Comments
Dossier availability date: Q2 2024
Manufacturer #32970
This company is a leading manufacturer of pharmaceutical products, specializing in pellets and granules, tablets, capsules, creams, and ointments. They have a strong track record of success, with GMP certifications from the EU, TGA (Australia), ANVISA (Brazil), and other regulatory bodies. Their expertise extends to multiple therapy areas, leveraging their manufacturing capabilities across various dosage forms. The company caters to a global market, exporting to over 47 countries across regions including North America, South America, Asia, and Europe. They are recognized for their commitment to quality, innovation, and technological advancements in manufacturing processes.

Manufacturer usually replies in 9 days

Want to see all 10 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible